ESRRA and osteosarcoma: He et al. discussed the potential role of metabolic reprogramming in acquired drug resistance of osteosarcoma and the regulatory mechanisms underlying this process; these authors showed that increased ERRα expression is related to the metabolic reprogramming of chemotherapy-resistant osteosarcoma cells, because the targeted inhibition of ERRα expression restores the transformation of the metabolic mode [45].